• Contacto
En
  • Es
logo-2k25logo-2k25logo-2k25logo-2k25
  • About us
    • What is NEUROFAN?
    • Who are we?
    • Where are we?
    • Contact
  • Publications
  • Projects
    • Aging and dementias
    • Pharmacogenomics and pharmacoepigenomics
    • Research in Addictive Disorders
    • Neuroinflammation and neurodegeneration
  • Resources
    • Links of interest
    • Multimedia
  • News
    • NEUROFAN in the media
    • Communications
✕
Study of the pharmacological inhibition of RPTP ????/( as a novel strategy to modulate the LPS-induced loss of neuronal progenitors in the dentate gyrus
Receptor Protein Tyrosine Phosphatase β/ζ regulates ethanol intake and ethanol effects on hippocampal neurogenesis and neuroimmune response in a sex-dependent manner
The discovery of a protein that can be potentially useful as a therapeutic target for the treatment of Alzheimer’s
Russian soldiers who occupied Chernobyl could suffer from burns, hair loss and cancer
The Spanish pharmaceutical system, the future of the pharmaceutical profession and the importance of pharmaceutical care and pharmacotherapeutic follow-up
The future of the pharmaceutical profession and the importance of pharmaceutical care and pharmacotherapeutic follow-up
CEU researchers find possible improvements in the treatment of Parkinson’s
Chemical submission drugs: effects, uses and prevention
Adefarma and Bidafarma reward a work on opioids in breakthrough cancer pain
12345

Grupo Neurofarmacología de las adicciones y los trastornos degenerativos NEUROFAN

2025 Fundación Universitaria San Pablo CEU. Todos los derechos reservados

Contacto Aviso legal Política de privacidad Política de cookies
    • English
    • Español
    • Contacto

      En
      • Es
      cerrar-popup

      • English
      • Español (Spanish)